In Eritrea, the pregnant women living with hiv antiretroviral therapy coverage for pmtct currently stands at 93%, reflecting an increase of 9% (10.7%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Eritrea
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Eritrea
Eritrea PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 93% | +9% |
| 2021 | 84% | -16% |
| 2020 | 100% | +11% |
| 2019 | 89% | -11% |
| 2018 | 100% | +9% |
| 2017 | 91% | +11% |
| 2016 | 80% | -20% |
| 2015 | 100% | 0% |
| 2014 | 100% | 0% |
| 2013 | 100% | 0% |
| 2012 | 100% | +40% |
| 2011 | 60% | +23% |
| 2010 | 37% | -63% |
| 2009 | 100% | 0% |
| 2008 | 100% | 0% |
| 2007 | 100% | +69% |
| 2006 | 31% | -7% |
| 2005 | 38% | +27% |
| 2004 | 11% | +4% |
| 2003 | 7% | +4% |
| 2002 | 3% | +3% |
| 2001 | 0% | 0% |
| 2000 | 0% |